Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 15 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

8(72.7%)

Phase 2

1(9.1%)

Phase 3

1(9.1%)

Phase 4

1(9.1%)

11Total

N/A(8)

Phase 2(1)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials

NCT07230743Not ApplicableRecruiting

The Study Evaluates the Effect of an Interactive Projector as a Distraction for Children During Anesthetic Induction. The Primary Objective is to Reduce Perioperative Anxiety, Measured With the Modified Yale Preoperative Anxiety Scale (mYPAS).

Role: lead

NCT07086365Not ApplicableCompleted

Feasibility of Using Immersive Virtual Functional Rehabilitation for Recovery of Upper Extremity Function in Patients With Early-stage Stroke: a Pilot Study

Role: lead

NCT06987669Not Yet Recruiting

Gastric Emptying in Healthy Volunteers and GLP-1 Agonist Users

Role: lead

NCT04904536Phase 3Active Not Recruiting

Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy

Role: collaborator

NCT04979897Completed

Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic

Role: collaborator

NCT06273397Not ApplicableNot Yet Recruiting

Acetazolamide or Metolazone in Acute Heart Failure